Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat.

scientific article published on 7 February 2007

Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1095/BIOLREPROD.106.059642
P698PubMed publication ID17287493

P50authorIstván KovaneczQ71914030
P2093author name stringRajfer J
Gonzalez-Cadavid NF
Vernet D
Sanchez S
Davila HH
Ferrini MG
P433issue5
P407language of work or nameEnglishQ1860
P921main subjecterectile dysfunctionQ184674
P304page(s)915-923
P577publication date2007-02-07
P1433published inBiology of ReproductionQ4915061
P1476titleLong-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat
P478volume76

Reverse relations

cites work (P2860)
Q382571652013-2014 updates in Peyronie's disease management
Q38406941Administration of Goji (Lycium chinense Mill.) Extracts Improves Erectile Function in Old Aged Rat Model
Q38738470Aging and sexual health: getting to the problem
Q37647240Aging related erectile dysfunction-potential mechanism to halt or delay its onset
Q35570950Amelioration of diabetes-induced cavernosal fibrosis by antioxidant and anti-transforming growth factor-β1 therapies in inducible nitric oxide synthase-deficient mice
Q46987652Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection
Q51548207Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function through increased endothelial dysfunction, oxidative stress, apoptosis, and corporal fibrosis in a rat model.
Q26775925Clinical and preclinical treatment of urologic diseases with phosphodiesterase isoenzymes 5 inhibitors: an update
Q37030511Daily use of phosphodiesterase 5 inhibitors for erectile dysfunction and lower urinary tract symptoms
Q37630425Diabetes and sexual dysfunction: current perspectives.
Q91297820Early improvement in SHIM scores with Revactin®
Q46738229Effect of muscle-derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat.
Q48459547Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat.
Q30462352Effects of sildenafil and/or muscle derived stem cells on myocardial infarction
Q87946329Effects of the recreational use of PDE5 inhibitors on the corpus cavernosum of young, healthy rats
Q37594796Efficacy of Cinnamomum cassia Blume. in age induced sexual dysfunction of rats
Q62029106Erectile dysfunction
Q34403822Erectile hydraulics: maximizing inflow while minimizing outflow
Q42781883Erectile tissue molecular alterations with aging: differential activation of the p42/44 MAP Kinase pathway
Q37171963Erectogenic and Aphrodisiac Effects of Butea frondosa Koenig ex Roxb. in Rats: Involvement of Enzyme Inhibition
Q42696988Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue.
Q37373199Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat.
Q37085433Improvement of erectile function by Korean red ginseng (Panax ginseng) in a male rat model of metabolic syndrome
Q46991340Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats.
Q38568077PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.
Q51134530Penile rehabilitation after pelvic cancer surgery.
Q26773762Penile rehabilitation after radical prostatectomy: does it work?
Q21328700Penile rehabilitation therapy with PDE-V inhibitors following radical prostatectomy: proceed with caution
Q26768640Peyronie's disease: What's around the bend?
Q37865017Peyronie's disease: perspectives on therapeutic targets
Q86490946Pharmacokinetic interaction between Kaempferia parviflora extract and sildenafil in rats
Q37526780Prediction of sexual function after radical prostatectomy.
Q89475315Reduction of oxidative stress markers in the corpora cavernosa and media of penile dorsal artery in middle-aged rats treated with COMP-4
Q55078470Safety and efficacy of daily Revactin® in men with erectile dysfunction: a 3-month pilot study.
Q35610039Senescent Cells Impair Erectile Function through Induction of Endothelial Dysfunction and Nerve Injury in Mice
Q41600750Separate or combined treatments with daily sildenafil, molsidomine, or muscle-derived stem cells prevent erectile dysfunction in a rat model of cavernosal nerve damage.
Q34486470Sildenafil attenuates inflammation and oxidative stress in pelvic ganglia neurons after bilateral cavernosal nerve damage
Q43485171Sildenafil citrate improves erectile function after castration in a rat model
Q34788065Sildenafil promotes smooth muscle preservation and ameliorates fibrosis through modulation of extracellular matrix and tissue growth factor gene expression after bilateral cavernosal nerve resection in the rat
Q43007162Testosterone and chronic sildenafil/tadalafil anti-apoptotic role in aged diabetic rats
Q90054817The Effects of Calorie Restriction and Exercise on Age-Related Alterations in Corpus Cavernosum
Q36463526The aging penis: what is it trying to tell us?
Q91785916The two phases of the clinical validation of preclinical translational mechanistic research on PDE5 inhibitors since Viagra's advent. A personal perspective
Q38902584Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction
Q37704966Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy
Q36082711Treatment with a combination of ginger, L-citrulline, muira puama and Paullinia cupana can reverse the progression of corporal smooth muscle loss, fibrosis and veno-occlusive dysfunction in the aging rat.
Q38630432Treatments for fibrosis of the corpora cavernosa
Q45938670[Cavernous tissue rehabilitation whit sildenafil 100 mg in patients after radical prostatectomy].

Search more.